Fundz

Gyre Therapeutics reported raising $5 Million in an initial SEC Form D filing, from an offering of $5 Million

PUBLIC · GYRENov 13, 2023

Amount Raised

$5 Million

$5 Million sold, per SEC Form D (first sale Oct 30, 2023)

Round Type

Venture

San DiegoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsBiopharma

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Gyre Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Os Therapies raised $700K on December 8, 2023.
  • Lipella Pharmaceuticals raised $3.1M (Seed) on October 23, 2023.
  • Procyrion raised $58M on December 13, 2023.
  • TuHURA Biosciences raised $1.7M (Seed) on December 11, 2023.
  • Phio Pharmaceuticals raised $533K (Seed) on December 8, 2023.
  • Tenon Medical raised $1.3M (Seed) on November 21, 2023.

Who to call at Gyre Therapeutics, and when

A new round usually means Gyre Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gyre Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gyre Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gyre Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gyre Therapeutics

Location

12730 High Bluff Drive

San Diego, California, United States

About

Gyre Therapeutics is an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases. The company focuses on developing treatments for inflammatory diseases and cancers. Gyre aims to leverage its capabilities for manufacturing and commercialization.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gyre Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Gyre Therapeutics's next move

See what Strategic adds

Gyre Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.